Involvement of Laryngopharyngeal Reflux in Ocular Diseases: A State-of-the-Art Review
- PMID: 33849761
- DOI: 10.1016/j.jvoice.2021.03.010
Involvement of Laryngopharyngeal Reflux in Ocular Diseases: A State-of-the-Art Review
Abstract
Background: Laryngopharyngeal reflux-associated symptoms embrace a wide variety of head and neck manifestations. Its participation in eye disorders has recently been postulated, and there is currently no consensus in this regard. The aim of this manuscript is to review the role of reflux in the development of ocular signs and symptoms, and its physio-pathological mechanisms.
Methods: A systematic approach based on the preferred reporting Items for a systematic review and meta-analysis checklist with a modified population, intervention, comparison, and outcome framework was used to structure the review process of studies that evaluated the possible association, with clear diagnostic methods, of laryngopharyngeal reflux and ocular signs and symptoms. Search was conducted in different indexed databases (PubMed/MEDLINE, the Cochrane Library, Scielo and Web of Science) and through the meta-searcher Trip Database with the keywords: reflux, laryngitis, laryngopharyngeal, gastroesophageal, ocular, eye, symptoms, signs, conjunctivitis, keratitis, dacryocystitis, dry eye.
Results: Seven studies met the inclusion criteria, in which the primary acquired nasolacrimal duct obstruction and the ocular surface disease were evaluated. The local increase of eye pepsin concentration (>2.5 ng/mL) may affect ocular surface though its direct proteolytic activity and the local expression of proinflammatory cytokines. The H. Pylori, with a similar mechanism to reach the lacrimonasal duct, would be associated with the release of proinflammatory and vasoactive substances that would lead to a mucosa injury and chronic inflammation. Ocular Surface Disease Index seems to correlate directly with the reflux severity, with cut-off of 41.67 score as predictor for disease.
Discussion: The role of laryngopharyngeal reflux in the development of ocular disorders has not yet been demonstrated and data are limited and heterogeneous. It seems theoretically conceivable that pepsin may reach lachrymal duct area through hypopharyngeal-nasal gaseous reflux events. Future studies using objective testing for diagnosis and pepsin detection into the tear and nasal mucosa are needed in order to explore this potential relationship.
Keywords: Gastroesophageal reflux; H. Pylori; Laryngopharyngeal reflux; Nasolacrimal duct obstruction; OSDI; Ocular surface disease; Pepsin.
Copyright © 2021 The Voice Foundation. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Eliciting adverse effects data from participants in clinical trials.Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2. Cochrane Database Syst Rev. 2018. PMID: 29372930 Free PMC article.
-
Diagnostic utility of salivary pepsin in laryngopharyngeal reflux: a systematic review and meta-analysis.Braz J Otorhinolaryngol. 2023 Mar-Apr;89(2):339-347. doi: 10.1016/j.bjorl.2022.10.050. Epub 2022 Oct 29. Braz J Otorhinolaryngol. 2023. PMID: 36347787 Free PMC article.
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
Cited by
-
Bibliometric and visualized analysis of research hotpots and future prospects in lacrimal duct obstruction disease (1900 to 2024).Int J Ophthalmol. 2025 Mar 18;18(3):526-540. doi: 10.18240/ijo.2025.03.21. eCollection 2025. Int J Ophthalmol. 2025. PMID: 40103946 Free PMC article.
-
European clinical practice guideline: managing and treating laryngopharyngeal reflux disease.Eur Arch Otorhinolaryngol. 2024 Dec 24. doi: 10.1007/s00405-024-09181-z. Online ahead of print. Eur Arch Otorhinolaryngol. 2024. PMID: 39719472
-
Impact of Exposomes on Ocular Surface Diseases.Int J Mol Sci. 2023 Jul 10;24(14):11273. doi: 10.3390/ijms241411273. Int J Mol Sci. 2023. PMID: 37511032 Free PMC article. Review.
-
Clinical Update Findings about pH-Impedance Monitoring Features in Laryngopharyngeal Reflux Patients.J Clin Med. 2022 Jun 1;11(11):3158. doi: 10.3390/jcm11113158. J Clin Med. 2022. PMID: 35683545 Free PMC article. Review.
-
Xerostomia, sticky saliva and dysphonia.Eur Arch Otorhinolaryngol. 2023 Nov;280(11):5147-5148. doi: 10.1007/s00405-023-08171-x. Epub 2023 Aug 5. Eur Arch Otorhinolaryngol. 2023. PMID: 37542563 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous